1 |
D. F. Birt, B. Walker, M. G. Tibbels & E. Bresnick. (1986). Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis, 7, 959-963.
DOI
|
2 |
R. L.Siegel, K. D. Miller & A. Jemal (2016). Cancer statistics. CA Cancer J Clin, 66, 7-30.
DOI
|
3 |
O. Sadaki. (1996). The development of functional foods and material. Bio-industry, 13, 44-50.
|
4 |
X. Wang, Y. Ouyang, J. Liu, M. Zhu, G. Zhao & W. Bao. (2014). Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ, 349.
|
5 |
R. C. Garcia, C. A. Gonzalez, A. Agudo & E. Riboli. (1999). Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control, 10, 71-75.
DOI
|
6 |
M. Rossi, E. Negri, R. Talamini, C. Bosetti, M. Parpinel & P. Gnagnarella. (2006). Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev, 15, 1555-1558.
DOI
|
7 |
C. Bosetti, L. Spertini, M. Parpinel, P. Gnagnarella, P. Lagiou & E. Negri. (2005). Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev, 14, 805-808.
DOI
|
8 |
B. Rocca & G. A. FitzGerald. (2002). Cyclooxygenases and prostaglandins shaping up the immune response. Int. Immunopharmacol. 2, 603-607.
DOI
|
9 |
P. L. Horn-Ross, E. M. John, A. J. Canchola, S. L. Stewart, & M. M. Lee. (2003). Phytoestrogen intake and endometrial cancer risk. J. Natl. Cancer Inst, 95, 1158-1164.
DOI
|
10 |
C. L. Frankenfeld, J. R. Cerhan, W. Cozen, S. Davis, M. Schenk & L. M. Morton. (2008). Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am J. Clin Nutr, 87, 1439-1445.
DOI
|
11 |
H. Chisholm. (1911). Encyclopaedia Britannica. Cambridge University Press.
|
12 |
X. Tong, S. Mirzoeva, D. Veliceasa, B. B. Bridgeman, P. Fitchev, & M. L. Cornwell. (2014). Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1. Oncotarget, 5, 11413-11427.
DOI
|
13 |
S. Wolfgang. (2012). Celeriac (Apium graveolens rapaceum). Desirable Vegetable Varieties, By Vegetable. The Owlcroft Company.
|
14 |
P. T. Ana et al. (2015). The Effect of Apium Nodiflorum in Experimental Osteoporosis. Current Pharmaceutical Biotechnology, 16(5), 414-423.
DOI
|
15 |
J. H. Lee, H. J. Jeong, J. S. Park. (2021). Effect of Celeriac Extract on the LPS-Induced Production of Pro-inflammatory Cytokines by RAW 264.7 cells. Journal of the Korea Convergence Society, 12(2), 295-300,
DOI
|
16 |
L. Chunhua, L. Donglan, F. Xiuqiong, Z. Lihua, F. Qin, & L. Yawei. (2013). Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. J. Nutr. Biochem, 24, 1766-1775.
DOI
|
17 |
Growing Crops: Celery and Celeriac. (2011). Urban Organic.
|
18 |
D. F. Birt, B. Walker, M. G. Tibbels & E. Bresnick. (1986). Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis, 7, 959-963.
DOI
|
19 |
S. Shukla, P. Fu & S. Gupta. (2014). Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis, 19, 883-894.
DOI
|
20 |
B. Mafuvadze, Y. Liang, C. Besch-Williford, X. Zhang, & S. M. Hyder. (2012). Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Horm Cancer, 3, 160-171.
DOI
|
21 |
M. A. Gates, A. F. Vitonis, S. S. Tworoger, B. Rosner, L. Titus-Ernstoff & S. E. Hankinson. (2009). Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int. J. Cancer. 124, 1918-1925.
DOI
|
22 |
W. L. Chen & Y. Xiao. (2020). Apigenin protects against ischemia-/hypoxia-induced myocardial injury by mediating pyroptosis and apoptosis. In Vitro Cellular & Developmental Biology, 13, 307-312.
|
23 |
S. F Jin, H. L. Ma, Z. L. Liu, S. T. Fu, C. P. Zhang, & Y. He. (2015). XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4. Exp Cell Res, 10;339(2), 289-299.
DOI
|
24 |
S. Shukla, N. Bhaskaran, M. A. Babcook, P. Fu, G. T. Maclennan. & S. Gupta. (2014). Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis, 35, 452-460.
DOI
|
25 |
B. B. Bridgeman, P. Wang, B. Ye, J. C. Pelling, O. V. Volpert & X. Tong, (2016). Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention. Cell Signal, 28, 460-468.
DOI
|
26 |
I. Goleberg. (1994). Functional Foods. Chapman & Hall Press, New York, USA, 350-550.
|